Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells.

Proceedings of the National Academy of Sciences of the United States of America
Haiying LiuFoo Y Liew

Abstract

Toll-like receptors (TLRs) are primary sensors of both innate and adaptive immune systems and play a pivotal role in response against structurally conserved components of pathogens. Synthetic bacterial lipoprotein (BLP) Pam3Cys-SK4 is a TLR2 agonist that is capable of modulating T cell immune responses. We show here that BLP, together with anti-CD3 antibody [T cell receptor (TcR) activation], induced proliferation of both CD4+ CD25+ regulatory T cells (Tregs) and CD4+ CD25- (effector) T cells in the absence of antigen-presenting cells. The expanded Tregs showed a transient loss of suppressive activity. Moreover, BLP rendered effectors resistant to the suppression of Tregs by increasing IL-2 secretion. BLP also transiently suppressed the induction of Foxp3 (X-linked forkhead/winged helix transcription factor) mRNA in Tregs at the first 8-15 h after T cell receptor activation. Consistent with this observation, BLP-stimulated Tregs regained their inhibitory activity and prevented spontaneous colitis induced by effectors in severe combined immunodeficient mice. Our results demonstrate a previously unrecognized pathway by which TLR expressed on T cells may directly modulate the immune response. Thus, during an acute bacterial infect...Continue Reading

References

Jun 16, 1997·The Journal of Experimental Medicine·D F ToughJ Sprent
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MuzioA Mantovani
Feb 28, 2002·Annual Review of Immunology·Charles A Janeway, Ruslan Medzhitov
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Damo XuFoo Y Liew
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Jan 14, 2003·Annual Review of Immunology·Kiyoshi TakedaShizuo Akira
Jan 18, 2003·Science·Chandrashekhar Pasare, Ruslan Medzhitov
Feb 20, 2003·The Journal of Experimental Medicine·Iris CaramalhoJocelyne Demengeot
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Mar 4, 2003·Nature Immunology·Roli KhattriFred Ramsdell
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christian MottetFiona Powrie
Jul 23, 2003·The Journal of Experimental Medicine·Sayuri YamazakiRalph M Steinman
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Haiying LiuFoo Y Liew
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mousa Komai-KomaFoo Y Liew
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mihai G NeteaBart Jan Kullberg
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela M ThorntonEthan M Shevach
Oct 7, 2004·International Immunology·Haruhiko YagiShimon Sakaguchi
Nov 3, 2004·International Immunology·Zoltán Fehérvári, Shimon Sakaguchi
Nov 13, 2004·Immunity·Chandrashekhar Pasare, Ruslan Medzhitov
Dec 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takekazu KuboCasey T Weaver
Dec 15, 2004·Microbes and Infection·Chandrashekhar Pasare, Ruslan Medzhitov
Jun 4, 2005·Advances in Experimental Medicine and Biology·Chandrashekhar Pasare, Ruslan Medzhitov
Aug 27, 2005·Science·Guangyong PengRong-Fu Wang
Dec 13, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Natasha K CrellinMegan K Levings

❮ Previous
Next ❯

Citations

Feb 26, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Qiang ZhouHao Cheng
Aug 4, 2010·Cell and Tissue Research·Raveendra KulkarniShayan Sharif
Sep 9, 2010·Cell and Tissue Research·Jayaum BoothGeorge Mutwiri
Nov 17, 2011·Protoplasma·Rose A K WhelanSebastian Rausch
Sep 24, 2008·Journal of Clinical Immunology·Elizabeth Wohlfert, Yasmine Belkaid
Jul 3, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Giulio PoddaBruno Gran
Feb 14, 2012·Targeted Oncology·Christine Ménétrier-CauxWeiping Zou
Apr 29, 2010·Current Allergy and Asthma Reports·Hermelijn H SmitsMaria Yazdanbakhsh
Jul 16, 2008·Clinical Reviews in Allergy & Immunology·Birgit Terjung, Ulrich Spengler
Jul 15, 2009·Immunologic Research·Adeeb H RahmanLaurence A Turka
Oct 16, 2012·Pathology Oncology Research : POR·Yizhen ShenAimin Zhang
Mar 7, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·L Keoki WilliamsChristine C Johnson
Jun 20, 2013·Nature Immunology·Hiutung Chu, Sarkis K Mazmanian
Oct 19, 2007·Nature Reviews. Cancer·Stephen S Myatt, Eric W-F Lam
Oct 20, 2007·Nature Reviews. Immunology·Yasmine Belkaid
Nov 19, 2011·Nature Reviews. Immunology·Kingston H G Mills
Mar 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·David F LaRosaLaurence A Turka
Jan 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jorge VeraFrancisco Lozano
Nov 20, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ying ZhangZhi-yong Sheng
Feb 3, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles N SerhanJohn L Wallace
Apr 7, 2007·Current Opinion in Rheumatology·James W Verbsky
Dec 4, 2008·Critical Care Medicine·Ismail Cinel, Steven M Opal
Aug 10, 2010·The Cancer Journal·Tatiana N Golovina, Robert H Vonderheide
Jul 16, 2008·Transplantation·Maria-Luisa AlegreMichel Goldman
Oct 14, 2006·Annals of the Rheumatic Diseases·F Hauet-BroereW Van Eden
Nov 21, 2007·Annals of the Rheumatic Diseases·Roger SutmullerGosse J Adema
Mar 24, 2009·Annual Review of Immunology·Yasmine Belkaid, Kristin Tarbell
Jul 24, 2010·Mediators of Inflammation·Jennifer E ColeClaudia Monaco
Jul 31, 2010·Journal of Biomedicine & Biotechnology·Bo JinAnthony E T Yeo
Nov 24, 2011·Clinical & Developmental Immunology·Alja Oblak, Roman Jerala
Jun 28, 2012·Clinical & Developmental Immunology·Bo JinAnthony E T Yeo
Nov 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hailing LuMary L Disis
Jul 3, 2013·International Archives of Allergy and Immunology·Anna Stelmaszczyk-EmmelUrszula Demkow
Dec 2, 2006·American Journal of Respiratory and Critical Care Medicine·Ian SabroeMoira K B Whyte
Jul 19, 2008·American Journal of Respiratory and Critical Care Medicine·Mark M WurfelThomas R Martin
Oct 3, 2009·American Journal of Respiratory and Critical Care Medicine·Toshihiro ItoSteven L Kunkel
Dec 7, 2007·The Journal of Clinical Investigation·Shahla Abdollahi-RoodsazWim B van den Berg

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

The Journal of Clinical Investigation
Roger SutmullerGosse J Adema
Proceedings of the National Academy of Sciences of the United States of America
Mousa Komai-KomaFoo Y Liew
© 2022 Meta ULC. All rights reserved